BACKGROUND: Acute kidney injury (AKI) after cardiac surgery is associated with poor outcomes, but is challenging to predict from information available before surgery. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: The TRIBE-AKI (Translational Research Investigating Biomarker Endpoints in Acute Kidney Injury) Consortium enrolled 1,147 adults undergoing cardiac surgery at 6 hospitals from 2007-2009; participants were selected for high AKI risk. PREDICTORS: Presurgical values for cystatin C, creatinine, and creatinine-based estimated glomerular filtration rate (eGFR) were categorized into quintiles and grouped as "best" (quintiles 1-2), "intermediate" (quintiles 3-4), and "worst" (quintile 5) kidney function. OUTCOMES: The primary outcome was AKI Network (AKIN) stage 1 or higher; ≥0.3 mg/dL or 50% increase in creatinine level. MEASUREMENTS: Analyses were adjusted for characteristics used clinically for presurgical risk stratification. RESULTS: Average age was 71 ± 10 years (mean ± standard deviation); serum creatinine, 1.1 ± 0.3 mg/dL; eGFR-Cr, 74 ± 9 mL/min/1.73 m(2); and cystatin C, 0.9 ± 0.3 mg/L. 407 (36%) participants developed AKI during hospitalization. Adjusted odds ratios for intermediate and worst kidney function by cystatin C were 1.9 (95% CI, 1.4-2.7) and 4.8 (95% CI, 2.9-7.7) compared with 1.2 (95% CI, 0.9-1.7) and 1.8 (95% CI, 1.2-2.6) for creatinine and 1.0 (95% CI, 0.7-1.4) and 1.7 (95% CI, 1.1-2.3) for eGFR-Cr categories, respectively. After adjustment for clinical predictors, the C statistic to predict AKI was 0.70 without kidney markers, 0.69 with creatinine, and 0.72 with cystatin C. Cystatin C also substantially improved AKI risk classification compared with creatinine, based on a net reclassification index of 0.21 (P < 0.001). LIMITATIONS: The ability of these kidney biomarkers to predict risk of dialysis-requiring AKI or death could not be assessed reliably in our study because of a small number of patients with either outcome. CONCLUSIONS: Presurgical cystatin C is better than creatinine or creatinine-based eGFR at forecasting the risk of AKI after cardiac surgery. Published by Elsevier Inc.
BACKGROUND:Acute kidney injury (AKI) after cardiac surgery is associated with poor outcomes, but is challenging to predict from information available before surgery. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: The TRIBE-AKI (Translational Research Investigating Biomarker Endpoints in Acute Kidney Injury) Consortium enrolled 1,147 adults undergoing cardiac surgery at 6 hospitals from 2007-2009; participants were selected for high AKI risk. PREDICTORS: Presurgical values for cystatin C, creatinine, and creatinine-based estimated glomerular filtration rate (eGFR) were categorized into quintiles and grouped as "best" (quintiles 1-2), "intermediate" (quintiles 3-4), and "worst" (quintile 5) kidney function. OUTCOMES: The primary outcome was AKI Network (AKIN) stage 1 or higher; ≥0.3 mg/dL or 50% increase in creatinine level. MEASUREMENTS: Analyses were adjusted for characteristics used clinically for presurgical risk stratification. RESULTS: Average age was 71 ± 10 years (mean ± standard deviation); serum creatinine, 1.1 ± 0.3 mg/dL; eGFR-Cr, 74 ± 9 mL/min/1.73 m(2); and cystatin C, 0.9 ± 0.3 mg/L. 407 (36%) participants developed AKI during hospitalization. Adjusted odds ratios for intermediate and worst kidney function by cystatin C were 1.9 (95% CI, 1.4-2.7) and 4.8 (95% CI, 2.9-7.7) compared with 1.2 (95% CI, 0.9-1.7) and 1.8 (95% CI, 1.2-2.6) for creatinine and 1.0 (95% CI, 0.7-1.4) and 1.7 (95% CI, 1.1-2.3) for eGFR-Cr categories, respectively. After adjustment for clinical predictors, the C statistic to predict AKI was 0.70 without kidney markers, 0.69 with creatinine, and 0.72 with cystatin C. Cystatin C also substantially improved AKI risk classification compared with creatinine, based on a net reclassification index of 0.21 (P < 0.001). LIMITATIONS: The ability of these kidney biomarkers to predict risk of dialysis-requiring AKI or death could not be assessed reliably in our study because of a small number of patients with either outcome. CONCLUSIONS: Presurgical cystatin C is better than creatinine or creatinine-based eGFR at forecasting the risk of AKI after cardiac surgery. Published by Elsevier Inc.
Authors: Ron Wald; Orfeas Liangos; Mary C Perianayagam; Alexey Kolyada; Stefan Herget-Rosenthal; C David Mazer; Bertrand L Jaber Journal: Clin J Am Soc Nephrol Date: 2010-06-03 Impact factor: 8.237
Authors: Michael G Shlipak; Ronit Katz; Linda F Fried; Nancy Swords Jenny; Catherine O Stehman-Breen; Anne B Newman; David Siscovick; Bruce M Psaty; Mark J Sarnak Journal: J Am Coll Cardiol Date: 2005-01-18 Impact factor: 24.094
Authors: J A Magovern; T Sakert; G J Magovern; D H Benckart; J A Burkholder; G A Liebler; G J Magovern Journal: J Am Coll Cardiol Date: 1996-11-01 Impact factor: 24.094
Authors: G M Chertow; J M Lazarus; C L Christiansen; E F Cook; K E Hammermeister; F Grover; J Daley Journal: Circulation Date: 1997-02-18 Impact factor: 29.690
Authors: Michael G Shlipak; Mark J Sarnak; Ronit Katz; Linda F Fried; Stephen L Seliger; Anne B Newman; David S Siscovick; Catherine Stehman-Breen Journal: N Engl J Med Date: 2005-05-19 Impact factor: 91.245
Authors: Charuhas V Thakar; Susana Arrigain; Sarah Worley; Jean-Pierre Yared; Emil P Paganini Journal: J Am Soc Nephrol Date: 2004-11-24 Impact factor: 10.121
Authors: Berthus G Loef; Anne H Epema; Ton D Smilde; Robert H Henning; Tjark Ebels; Gerjan Navis; Coen A Stegeman Journal: J Am Soc Nephrol Date: 2004-11-24 Impact factor: 10.121
Authors: Tomas Jernberg; Bertil Lindahl; Stefan James; Anders Larsson; Lars-Olof Hansson; Lars Wallentin Journal: Circulation Date: 2004-10-11 Impact factor: 29.690
Authors: D B Williams; R G Carrillo; E A Traad; C H Wyatt; R Grahowksi; S H Wittels; G Ebra Journal: Ann Thorac Surg Date: 1995-10 Impact factor: 4.330
Authors: William R Zhang; Amit X Garg; Steven G Coca; Philip J Devereaux; John Eikelboom; Peter Kavsak; Eric McArthur; Heather Thiessen-Philbrook; Colleen Shortt; Michael Shlipak; Richard Whitlock; Chirag R Parikh Journal: J Am Soc Nephrol Date: 2015-04-08 Impact factor: 10.121
Authors: Jeremiah R Brown; Heather Thiessen-Philbrook; Christine A Goodrich; Andrew R Bohm; Shama S Alam; Steven G Coca; Eric McArthur; Amit X Garg; Chirag R Parikh Journal: Ann Thorac Surg Date: 2019-03-14 Impact factor: 4.330
Authors: Meyeon Park; Michael G Shlipak; Heather Thiessen-Philbrook; Amit X Garg; Jay L Koyner; Steven G Coca; Chirag R Parikh Journal: Ann Thorac Surg Date: 2016-02-26 Impact factor: 4.330
Authors: Dana Hoffmann; Vanesa Bijol; Aparna Krishnamoorthy; Victoria R Gonzalez; Gyorgy Frendl; Qin Zhang; Peter L Goering; Ronald P Brown; Sushrut S Waikar; Vishal S Vaidya Journal: Am J Pathol Date: 2012-07-20 Impact factor: 4.307
Authors: Jay L Koyner; Amit X Garg; Steven G Coca; Kyaw Sint; Heather Thiessen-Philbrook; Uptal D Patel; Michael G Shlipak; Chirag R Parikh Journal: J Am Soc Nephrol Date: 2012-03-01 Impact factor: 10.121
Authors: Haiqun Lin; Rebecca Scherzer; Heather Thiessen Philbrook; Steven G Coca; Francis Perry Wilson; Amit X Garg; Michael G Shlipak; Chirag R Parikh Journal: Biomark Med Date: 2017-11-27 Impact factor: 2.851